Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Pharmacology and Therapeutics|June 2, 2019
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated MalariaPalang Chotsiri, Lise Denoeud-Ndam, Elisabeth Baudin, et al.BMC Infectious Diseases|June 13, 2015
A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT studyLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.Malaria Journal|July 23, 2013
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaBirgit Schramm, Parastou Valeh, Elisabeth Baudin, et al.Malaria Journal|July 23, 2013
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trialBirgit Schramm, Parastou Valeh, Elisabeth Baudin, et al.Open Forum Infectious Diseases|August 27, 2015
Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical TrialJuliet Mwanga-Amumpaire, Ryan W Carroll, Elisabeth Baudin, et al.BMC Medicine|October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and NigerLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.The New England Journal of Medicine|January 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.The Lancet. Respiratory Medicine|July 19, 2025
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trialLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.Pageof 2